Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Webinars
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Home

Ruchika Sharma

Articles By : Ruchika Sharma

IPA Secretary General says Indian pharma industry likely to grow to USD 130 billion by 2030

Ruchika Sharma16 Sept 2022 11:15 AM IST

Dr Viranchi Shah opined that PLIs and cluster manufacturing will reduce India's dependence on imports.

Health Regulator geared up for smooth transition to licensing of Class A and B Medical Devices

Ruchika Sharma15 Sept 2022 5:30 PM IST

New Delhi: The reconstituted National Medical Device Promotion Council (NMDPC) under the Department of Pharmaceuticals, in its first meeting held at...

Serum Institute of India to produce vaccines with Nigeria

Ruchika Sharma15 Sept 2022 4:00 PM IST

Nigeria: Nigeria will partner with Serum Institute of India to start local manufacturing of vaccines used in the country's immunisation programmes,...

Lancet report on unapproved antibiotic use in India is 'misleading, inappropriate': Govt official

Ruchika Sharma15 Sept 2022 2:41 PM IST

"Even though the authors have used the term 'unapproved' for formulations not approved by CDSCO, it is pertinent to note that these formulations were...

Moderna bivalent COVID booster vaccine gets interim nod in Singapore

Ruchika Sharma15 Sept 2022 1:15 PM IST

Singapore: Singapore on Wednesday granted interim authorisation for a bivalent COVID-19 booster vaccine made by Moderna, the government said in a...

AstraZeneca discontinues Phase 3 trial of prostate cancer drug Truqap

AstraZeneca unveils iPHARMACY to up-skill pharmacists across India

Ruchika Sharma15 Sept 2022 12:00 PM IST

The program will focus on inventory management, good pharmacy practices, customization of pharmacy for patient of future, and management of pharmacy...

Pfizer begins Phase 3 clinical trial of mRNA-based Influenza vaccine

Ruchika Sharma15 Sept 2022 11:00 AM IST

New York: Pfizer Inc. has announced that the first participants have been dosed in a pivotal Phase 3 clinical trial to evaluate the...

Whistleblower case alleging kickback for promotion of Novartis MS drug Gilenya dismissed

Ruchika Sharma14 Sept 2022 2:30 PM IST

Novartis moved to dismiss, arguing that Camburn still had not offered enough detail to support his claim of a fraudulent scheme.

Novavax Nuvaxovid gets expanded conditional marketing authorization in EU for use as booster for adults aged 18 and older

Ruchika Sharma14 Sept 2022 1:15 PM IST

Gaithersburg: Biotechnology company, Novavax, Inc., has recently announced that the European Commission (EC) has approved the expanded conditional...

SII, Novavax report full product registration in South Africa of COVID jab NVX-CoV2373 for adults aged 18 and older

Ruchika Sharma14 Sept 2022 12:20 PM IST

Gaithersburg: Novavax, Inc., a biotechnology company and Serum Institute of India Pvt. Ltd. (SII), the world's largest vaccine manufacturer by...

Pfizer, BioNTech Omicron BA.4/BA.5-Adapted Bivalent COVID-19 Vaccine Booster get CHMP nod

Ruchika Sharma14 Sept 2022 11:37 AM IST

If an authorization is granted, the Pfizer-BioNTech bivalent Omicron BA.4/BA.5 COVID-19 vaccine will be available within the coming days to all 27 EU...

5 arrested with banned cough syrup stock

Paracetamol syrup sales suspended in Gambia over death of dozens of young children

Ruchika Sharma14 Sept 2022 9:00 AM IST

The children suffered symptoms including an inability to pass urine, fever and vomiting that quickly led to kidney failure.

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok